Involvement of aldose reductase in the metabolism of atherogenic aldehydes

Chemico-Biological Interactions

Volumn 130-132, Issue , 2001, Pages 563-571

  Srivastava, Sanjay ^a   Liu, Si Qi ^a   Conklin, Daniel J ^b   Zacarias, Albert ^a   Srivastava, Satish K ^c   Bhatnagar, Aruni ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF WISCONSIN EAU CLAIRE   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

1 Palmitoyl 2 (5 oxovaleroyl) sn glycero 3 phosphorylcholine; 4 Hydroxy trans 2 nonenal; Aldose reductase; Atherosclerosis; Lipid peroxidation

Indexed keywords

ALDEHYDE DERIVATIVE; ALDEHYDE REDUCTASE; GLUTATHIONE DERIVATIVE; GLYCEROPHOSPHOLIPID; LOW DENSITY LIPOPROTEIN; NONANOIC ACID; PHOSPHORYLCHOLINE;

ATHEROGENESIS; CATALYST; CONFERENCE PAPER; ENZYME MECHANISM; ENZYME STABILITY; HUMAN; HUMAN CELL; INFLAMMATION; LIPID PEROXIDATION; MASS SPECTROMETRY; METABOLISM; OXIDATIVE STRESS; REDUCTION;

ALDEHYDE REDUCTASE; ALDEHYDES; ARTERIOSCLEROSIS; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GLUTATHIONE; HUMANS; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; PHOSPHOLIPID ETHERS;

EID: 0035969857     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(00)00299-4     Document Type: Conference Paper

References (20)

1. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
2. Lipoperoxidation in hepatic subcellular compartments of diabetic rats
3. Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype
4. Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid
5. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma
6. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo
7. Low density lipoprotein oxidation and its pathobiological significance
8. Role of oxidized low density lipoprotein in atherogenesis
9. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma
10. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides
11. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins
12. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: Evidence that oxidation-specific epitopes mediate macrophage recognition
13. Metabolism of the lipid peroxidation product, 4-hydroxy-2-nonenal, in isolated perfused rat heart
14. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils
15. Nephrotoxicity of the 1:1 acrolein-glutathione adduct in the rat
16. Genotoxic effects of the alpha, beta-unsaturated aldehydes 2-trans-butenal, 2-trans-hexenal and 2-trans, 6-cis-nonadienal
17. Acrolein-induced oxygen radical formation
18. Biologically active oxidized phospholipids